The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Nov 2019 07:00

RNS Number : 2918U
Science in Sport PLC
22 November 2019
 

 

22 November 2019

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

Trading Update

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces an update on trading to date for the financial year ending 31 December 2019.

 

2019 has seen rapid progress at the Company. The integration of the PhD acquisition has been completed on time, with synergies already being achieved in line with plan, and the growth rate of the PhD brand has doubled over historic rates. The SiS brand has continued to grow strongly, in line with its six-year compound annual growth rate of more than 25%. Growth from the strategic priorities of both e-commerce and international markets has also been strong.

 

As a result, total sales growth for the year to 31 December 2019 is expected to be slightly ahead of market expectations, with sales momentum into 2020 underpinned by operational progress including a new PhD.com e-commerce platform and a new protein powder line, which is now in full production.

 

During the current half, the Group has absorbed a global whey price increase and also a foreign exchange effect relating to very strong sales of Smart Bars. As a consequence, the previously expected small EBITDA profit of £0.3m for the year is now anticipated to be a small EBITDA loss.

 

Cash balances at the year-end are expected to be in line with management expectations at approximately £5.3m.

 

The outlook for the remaining few weeks of the current year and for 2020 continues to be strong, underpinned by a robust innovation pipeline, the current year's operational progress and a continued strategic focus on e-commerce and international markets.

 

The Company will issue its full year trading update for the year ending 31 December 2019 in the week commencing 13 January 2020.

 

Stephen Moon, Science in Sport's Chief Executive Officer, commented:

"Our strategy is on-track and, in the year to 31 December 2019, we expect a record year of growth from PhD and another year of consistently high growth from SiS. The integration of PhD completed as planned and we are already seeing strong trading metrics from the PhD.com website in addition to significantly improved efficiencies in our new e-commerce fulfilment unit. Our in-house protein powder line was launched earlier this week, on time and under budget.

 

"The Board remains confident about the outlook for 2020 and beyond as we invest in our growth priorities of e-commerce and international markets. Gross margin remains robust, costs are tightly controlled and our cash position is healthy, allowing us to be confident in our long term growth trajectory."

 

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames Greenwood

+44 (0) 20 3100 2000

Buchanan CommunicationsFinancial PR

Mark CourtVicky HaynsTilly Abraham

+44 (0) 20 7466 5000

ScienceInSport@buchanan.uk.com

 

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' own websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD is the exclusive sports nutrition supplier to David Lloyd Clubs and its brand ambassadors include rapper Bugzy Malone, WBA international champion Jordan Gill and Team GB Olympic sprinter Asha Philip.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional cycling teams and organisations including Team INEOS, British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 80 professional football clubs in the UK and is an official partner to British Triathlon and the Rock 'n' Roll Marathon Series. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFLLLSLLFIA
Date   Source Headline
12th Aug 20163:03 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20163:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Aug 20167:00 amRNSOfficial Sports Nutrition Supplier for USA Cycling
21st Jul 20167:00 amRNSHalf Year Trading Update
23rd Jun 20161:03 pmRNSResult of AGM
8th Jun 201610:23 amRNSHolding(s) in Company
3rd Jun 20169:57 amRNSHolding(s) in Company
1st Jun 20164:54 pmRNSHolding(s) in Company
23rd May 20167:00 amRNSAnnual Report and Notice of AGM
6th May 20167:00 amRNSDirectorate Change
8th Apr 20164:20 pmRNSHolding(s) in Company
23rd Mar 20165:24 pmRNSIssue of Equity
22nd Mar 20165:08 pmRNSGrant of options
22nd Mar 20167:00 amRNSFinal Results
20th Jan 20167:00 amRNSTrading Statement
4th Jan 20162:25 pmRNSIssue of Equity
22nd Dec 20153:19 pmRNSHolding(s) in Company
19th Nov 201511:33 amRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20159:05 amRNSHolding(s) in Company
16th Nov 201511:07 amRNSHolding(s) in Company
16th Nov 20157:00 amRNSNotification of Major Interest in Shares
11th Nov 201512:15 pmRNSResults of Firm Placing and Open Offer
23rd Oct 20157:00 amRNSFirm Placing and Open Offer
24th Sep 20157:00 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSDirectorate Change
21st Jul 20157:00 amRNSHalf Year Trading Update
14th Jul 20157:00 amRNSNotification of Major Interest in Shares
25th Jun 20153:15 pmRNSResult of AGM
18th Jun 20157:00 amRNSAppointment of Non-Executive Director
10th Jun 20152:15 pmRNSIssue of equity
16th Apr 20157:00 amRNSAnnual Report and Notice of AGM
13th Apr 20153:30 pmRNSNotification of Major Interest in Shares
26th Mar 20159:40 amRNSGrant of Options
26th Mar 20157:00 amRNSPreliminary Results
25th Feb 20157:02 amRNSNotification of Preliminary Results
12th Jan 20157:00 amRNSLaunches Whey Protein Range
23rd Dec 20143:56 pmRNSNotification of Major Interest in Shares
11th Dec 20147:00 amRNSInterim Results
21st Nov 20143:11 pmRNSNotification of Major Interest in Shares
5th Nov 20147:00 amRNSNotification of Interim Results
13th Oct 20147:00 amRNSNotification of Major Interest in Shares
9th Oct 20142:45 pmRNSNotification of Major Interest in Shares
1st Oct 20141:15 pmRNSDirector's Dealing
30th Sep 201411:00 amRNSResult of AGM
30th Sep 20147:00 amRNSAGM Statement and Half Year Trading Update
19th Aug 20145:01 pmRNSNotification of Major Interest in Shares
11th Aug 20142:50 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.